Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

2015 set to be a transitional year for Merck KGaA's health unit

2015 set to be a transitional year for Merck KGaA's health unit With other drugs such as colorectal cancer therapy Erbitux (cetuximab) also in decline, Merck is facing a challenging 2015 and is banking on its $2.85bn deal with Pfizer - signed last

BMS gives Erbitux rights to Lilly in the US

BMS gives Erbitux rights to Lilly in the US Our good work on Erbitux began with its development at ImClone and has continued with Bristol-Myers Squibb. ... Erbitux made $723m last year - up from $693m the year before - in the North America region.

Merck takes promotional responsibility for Erbitux in Japan

Merck takes promotional responsibility for Erbitux in Japan Currently co-promotes the drug withBristol-Myers Squibb.  . Merck has revealed it will take full promotional responsibility for metastatic colorectal cancer drug Erbitux in Japan, effective from May 1 this year. ... Erbitux (cetuximab) is a highly

England's Cancer Drugs Fund: Fixing a broken system

England's Cancer Drugs Fund: Fixing a broken system Merck KGaA's Erbitux (cetuximab):. for the second of third line treatment of metastatic colorectal cancer.

Pharma condemns Cancer Drugs Fund cuts

Pharma condemns Cancer Drugs Fund cuts Lilly. Alimta (pemetrexed). Lung cancer (2 indications). Merck KGaA. Erbitux (cetuximab).

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....